Business
Weight management surges as key category in TELUS Health's 2025 Drug Trends Report
Weight management surges as key category in TELUS Health's 2025 Drug Trends Report Cana...
About this update from Telus Corporation
[{"type":"text","content":"\n\n\n\n\n Weight management surges as key category in TELUS Health's 2025 Drug Trends Report\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n From Wegovy to Zepbound and potential Alzheimer's breakthroughs, TELUS Health reveals how science, economics and access can help reshape prescription drug coverage in\n \n Canada\n \n .\n \n\n\n\n New data from over 15 million people in\n \n Canada\n \n shows weight management drugs climbing 90.6 per cent since 2023; diabetes drugs hold top spot; biosimilar adoption up more than 27 per cent.\n \n\n\n\n\n TORONTO\n \n\n ,\n \n\n April 29, 2025\n \n\n /CNW/ - An anchor announcement at today's TELUS Health Annual Conference, TELUS Health revealed the results of its\n \n\n\n 2025 Drug Data Trends and National Benchmarks Report\n \n\n ,\n \n offering an industry-wide snapshot of prescription medication coverage in Canadian private drug plans. Among the report's key findings, weight management emerged as the fastest growing drug category in 2024, climbing from 54th position in 2016 to 17th position in 2024. Claims for weight management surged by 90.6 per cent since 2023, driven in part by the long-awaited launch of Wegovy (semaglutide) in\n \n Canada\n \n . The report also highlights that diabetes drugs maintain their top position among claims, while new data demonstrates that the transition to biosimilar drugs is driving consistent cost savings across private plans in all regions of the country.\n \n\n\n\n\n\n\n\n\n \"Private sector drug plans protect and increase access to pharmaceutical care, but they are in constant need of expert adjustment to ensure they continue to meet the needs of people in\n \n Canada\n \n ,\" said\n \n Martin Bélanger, Senior Vice-president, Payor & Provider Solutions, TELUS Health\n \n . \"During these uncertain times, we will continue to drive innovation by providing clarity on key trends, helping businesses identify opportunities to improve cost management, while making informed coverage decisions that will help their employees live healthier and happier live...